Back to results
US 2012/0100102 A1Published application
Cancer vaccine
AssigneeProcure Therapeutics Limited
InventorRichard Birnie
Life of this patent
Estimating the term…
Abstract
We disclose a vaccine comprising a pappalysin and vaccine compositions comprising a pappalysin.
Claims17
A vaccine composition comprising a pappalysin polypeptide, or antigenic part thereof, and an adjuvant and/or carrier.
A DNA vaccine composition comprising a nucleic acid molecule encoding a pappalysin polypeptide or antigenic part thereof.
A method of vaccinating a subject suffering from or having a predisposition to cancer comprising administering an effective amount of a vaccine composition comprising a pappalysin polypeptide, or antigenic part thereof and an adjuvant and/or carrier.
Dependencies are inferred from the claim text.